| Bioactivity | Carbimazole is an imidazole antithyroid agent and can be used for the research of Graves' disease. Carbimazole plays its role due to its rapid conversion to methylmercapto imidazole (MMI) in vivo and can be converted to methimazole in vitro[1]. | ||||||||||||
| Name | Carbimazole | ||||||||||||
| CAS | 22232-54-8 | ||||||||||||
| Formula | C7H10N2O2S | ||||||||||||
| Molar Mass | 186.23 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Nakashima, T. and A. Taurog, Rapid conversion of carbimazole to methimazole in serum; evidence for an enzymatic mechanism. Clin Endocrinol (Oxf), 1979. 10(6): p. 637-48. |
Carbimazole
CAS: 22232-54-8 F: C7H10N2O2S W: 186.23
Carbimazole is an imidazole antithyroid agent and can be used for the research of Graves' disease. Carbimazole plays its
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.